Baseline cognitive function is predictive of clinical disability progression in relapsing-remitting multiple sclerosis: a statistical approach

被引：1
|
作者：
Pellegrini, F. [1 ]
Xiao, J. [2 ]
Castrillo, C. [2 ]
Raghupathi, K. [3 ]
Pace, A. [1 ]
机构：
[1] Biogen, Biostat, Cambridge, MA USA
[2] Biogen, Worldwide Med, Cambridge, MA USA
[3] Biogen, Value Based Med, Cambridge, MA USA
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2015年 / 357卷
关键词：
D O I：
10.1016/j.jns.2015.08.1106
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1039
引用
收藏
页码：E315 / E315
页数：1
相关论文
共 50 条
  • [31] Clinical parameters at multiple sclerosis diagnosis and cognitive performance in relapsing-remitting multiple sclerosis patients
    Anabel Silva, Berenice
    Laura Saladino, Maria
    Eizaguirre, Barbara
    Alonso, Ricardo
    Cecilia Pita, Maria
    Merino, Angeles
    Yastremiz, Cecilia
    Cabral, Nadia
    Mariangeli, Aldana
    Vanotti, Sandra
    Garcea, Orlando
    Caceres, Fernando
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 151 - 152
  • [32] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [33] Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis
    Young, P. J.
    Lederer, C.
    Eder, K.
    Daumer, M.
    Neiss, A.
    Polman, C.
    Kappos, L.
    [J]. NEUROLOGY, 2006, 67 (05) : 804 - 808
  • [34] MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis
    Fulton, JC
    Grossman, RI
    Udupa, J
    Mannon, LJ
    Grossman, M
    Wei, LG
    Polansky, M
    Kolson, DL
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 1999, 20 (10) : 1951 - 1955
  • [35] Predictive value of lesions for relapses in relapsing-remitting multiple sclerosis
    Koziol, JA
    Wagner, S
    Sobel, DF
    Slivka, LS
    Romine, JS
    Sipe, JC
    Adams, HP
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2001, 22 (02) : 284 - 291
  • [36] The effects of immunomodulatory treatments on the progression of relapsing-remitting multiple sclerosis
    Candan, E
    Yilmaz, Z
    Canturk, IA
    Isik, N
    Yildiz, N
    Seleker, T
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S234 - S235
  • [37] Impact of beta-interferon on disability progression in relapsing-remitting multiple sclerosis: a Bayesian analysis
    O'Rourke, K.
    Walsh, C.
    Hutchinson, M.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 102 - 103
  • [38] Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis
    Jung, P.
    Beyerle, A.
    Ziemann, U.
    [J]. MULTIPLE SCLEROSIS, 2008, 14 (04): : 553 - 556
  • [39] Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis
    Shirani, Afsaneh
    Zhao, Yinshan
    Karim, Mohammad Ehsanul
    Evans, Charity
    Kingwell, Elaine
    van der Kop, Mia L.
    Oger, Joel
    Gustafson, Paul
    Petkau, John
    Tremlett, Helen
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (03): : 247 - 256
  • [40] Clinical predictors of disability in treatment-naive relapsing-remitting multiple sclerosis patients
    Ivaniuk, A.
    Solodovnikova, I.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 921 - 921
12345